February 21, 2018 / 9:12 PM / 6 months ago

BRIEF-GW Pharma Says Mid Stage Study Of Seizures Drug Failed Main Goal

Reuters Staff

1 Min Read

Feb 21 (Reuters) - GW Pharmaceuticals Plc:

* GW PHARMACEUTICALS ANNOUNCES PRELIMINARY RESULTS OF PHASE 2A STUDY FOR ITS PIPELINE COMPOUND GWP42006

* GW PHARMA - PHASE 2A PROOF OF CONCEPT STUDY OF A PIPELINE COMPOUND GWP42006 IN ADULT PATIENTS WITH FOCAL SEIZURES DID NOT MEET ITS PRIMARY ENDPOINT Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below